Peiqing Zhang is the Strategic Technology Partnership Leader at Cytiva for Genomic Medicine. As a member of the Chief Scientific Officer’s team, he leads technology management and collaboration programs in Asia.

Peiqing has more than 18 years of experience in biotech research, development, and commercial manufacturing. He earned his PhD from National University of Singapore (NUS) and then became a research group leader in Agency for Science, Technology and Research (A*STAR). Moving to the biotech industry, Peiqing joined Novartis Singapore leading the Analytical Science &Technology (AS&T) and Manufacturing Science &Technology (MS&T) Process Science functions. Between 2018 to 2019, he was with Transcenta as CMC Leader and Senior Director of Analytical Science.

Peiqing is an active member of the International Society of Pharmaceutical Engineering (ISPE), and currently serves as the Vice President of ISPE Singapore Affiliate.